Ameritas Investment Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.17M | Sell |
17,302
-55
| -0.3% | -$3.66K | 0.03% | 588 |
|
|
2026
Q1 | $1.09M | Sell |
17,357
-317
| -2% | -$22.1K | 0.03% | 567 |
|
|
2025
Q4 | $1.17M | Buy |
17,674
+1,021
| +6% | +$66K | 0.04% | 547 |
|
|
2025
Q3 | $1.12M | Buy |
16,653
+107
| +0.6% | +$8.47K | 0.03% | 570 |
|
|
2025
Q2 | $1.44M | Sell |
16,546
-38
| -0.2% | -$2.98K | 0.05% | 466 |
|
|
2025
Q1 | $1.13M | Buy |
16,584
+351
| +2% | +$28.6K | 0.04% | 572 |
|
|
2024
Q4 | $1.26M | Buy |
16,233
+5
| +0% | +$370 | 0.04% | 536 |
|
|
2024
Q3 | $1.09M | Buy |
16,228
+509
| +3% | +$41.8K | 0.04% | 602 |
|
|
2024
Q2 | $1.78M | Buy |
15,719
+343
| +2% | +$43.4K | 0.06% | 348 |
|
|
2024
Q1 | $2.13M | Sell |
15,376
-123
| -0.8% | -$15.5K | 0.07% | 309 |
|
|
2023
Q4 | $1.92M | Buy |
15,499
+284
| +2% | +$29K | 0.07% | 320 |
|
|
2023
Q3 | $1.42M | Buy |
15,215
+2,140
| +16% | +$241K | 0.06% | 406 |
|
|
2023
Q2 | $1.68M | Buy |
13,075
+136
| +1% | +$16.4K | 0.06% | 356 |
|
|
2023
Q1 | $1.5M | Buy |
12,939
+67
| +0.5% | +$7.5K | 0.06% | 402 |
|
|
2022
Q4 | $1.37M | Sell |
12,872
-777
| -6% | -$85.3K | 0.05% | 462 |
|
|
2022
Q3 | $1.1M | Buy |
13,649
+69
| +0.5% | +$5.84K | 0.05% | 478 |
|
|
2022
Q2 | $1.01M | Buy |
13,580
+168
| +1% | +$15.3K | 0.04% | 526 |
|
|
2022
Q1 | $1.72M | Sell |
13,412
-140
| -1% | -$15.3K | 0.06% | 374 |
|
|
2021
Q4 | $1.82M | Sell |
13,552
-24
| -0.2% | -$3.45K | 0.06% | 372 |
|
|
2021
Q3 | $1.86M | Hold |
13,576
| – | – | 0.07% | 333 |
|
|
2021
Q2 | $1.45M | Buy |
13,576
+192
| +1% | +$18.4K | 0.05% | 450 |
|
|
2021
Q1 | $1.2M | Sell |
13,384
-184
| -1% | -$17.3K | 0.05% | 526 |
|
|
2020
Q4 | $1.25M | Buy |
13,568
+460
| +4% | +$41.1K | 0.06% | 444 |
|
|
2020
Q3 | $1.35M | Sell |
13,108
-152
| -1% | -$15.9K | 0.06% | 354 |
|
|
2020
Q2 | $1.34M | Buy |
+13,260
| New | +$1.19M | 0.06% | 345 |
|
|
2015
Q2 | – | Sell |
-26,852
| Closed | -$418K | – | 1176 |
|
|
2015
Q1 | $418K | Hold |
26,852
| – | – | 0.03% | 682 |
|
|
2014
Q4 | $370K | Hold |
26,852
| – | – | 0.03% | 739 |
|
|
2014
Q3 | $268K | Hold |
26,852
| – | – | 0.02% | 851 |
|
|
2014
Q2 | $266K | Buy |
26,852
+2,464
| +10% | +$21.8K | 0.02% | 884 |
|
|
2014
Q1 | $252K | Hold |
24,388
| – | – | 0.02% | 882 |
|
|
2013
Q4 | $216K | Buy |
+24,388
| New | +$193K | 0.02% | 945 |
|
Other funds holding DXCM
Ameritas Investment Partners's DXCM Position: Q2 2026 in Review
Ameritas Investment Partners reduced its DexCom (DXCM) stake by 0.32% in Q2 2026, selling an estimated $3.66K and leaving 17,302 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #588.
Ameritas Investment Partners first reported a position in DXCM in Q4 2013 and has held it in 31 quarters since. The position peaked at $2.13M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Ameritas Investment Partners held 17,302 shares of DexCom worth $1.17M as of Q2 2026.
- Ameritas Investment Partners sold 55 DexCom shares in Q2 2026, an estimated $3.66K.
- DexCom made up 0.03% of Ameritas Investment Partners's portfolio in Q2 2026, its #588 holding.
- Ameritas Investment Partners first reported a position in DexCom in Q4 2013 and has held it in 31 quarters since.
- Ameritas Investment Partners's DexCom position peaked at $2.13M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.